CA: Administration Core
CA: Administration Core
批准号:
7507325
负责人:
KENNETH C. ANDERSON
金额:
$14.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-07-01 至 2013-06-30
关键词:
Administrative CoordinationAdministratorAdvisory CommitteesApplications GrantsBusinessesCA-15-3 AntigenCancer CenterCenter Core GrantsChargeClinicalClinical Nursing ResearchClinical ResearchClinical TrialsCollaborationsCommunicationDataDevelopmentEducational ActivitiesEducational workshopEnsureEventFGFR3 geneFosteringFundingFutureGrantGuidelinesIndividualInstitutionIntellectual PropertyIntranetJointsLaboratory FindingLaboratory StudyLeadershipLicensingMonitorMultiple MyelomaNamesNodalOperative Surgical ProceduresPrincipal InvestigatorProgram DevelopmentProgress ReportsPublicationsPurposeReport (account)ReportingReproduction sporesResearchResearch InfrastructureResearch PersonnelResourcesRightsSamplingSecureSignal TransductionSiteSpecialistStructureSurvivorsTechnologyTechnology TransferTranslationsTravelWorkbench to bedsidecareercomplement resourcecostdayexperiencemembernovelpreclinical studyprogramsstemtrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of the Administration, Communication, and Planning Core is to assure the coordination of
the Dana Farber/Harvard Cancer Center (DF/HCC) Myeloma SPORE components and to provide oversight
and leadership of the scientific, administrative, and fiscal aspects of the SPORE. The SPORE Director will
oversee the administrative coordination of the various clinical and laboratory studies outlined in this Program.
He will integrate scientific and clinical efforts within and between Projects, and assure the translation of
laboratory findings to the bedside; and conversely, the initiation of laboratory studies stemming from clinical
observations.
During the prior funding period, the infrastructure has been created to have seemless communication
and exchange of data between SPORE sites, facilitating collaborative preclinical studies and clinical trials.
Multiple joint publications, completed and ongoing clinical trials, and the translation of several novel targeted
therapies from bench to bedside confirm the communication and integration of our efforts. This Core will
continue to facilitate exchange of information among the SPORE members, as well as the internal and
external advisory committees. It will provide clinical research nursing support for the proposed clinical trials.
In addition, as in the previous funding period, a clinical study coordinator will assure appropriate sample
acquisition and trafficking. The grants administrator will allocate resources in a timely and integrated fashion
to facilitate successful completion of the proposed studies. The Specific Aims of the Administration,
Communication, and Planning Core are to:
1. Monitor research progress and plan for the future;
i
2. Foster collaborative research within the SPORE and between SPOREs;
3. Integrate the Myeloma SPORE into the DF/HCC structure;
4. Provide necessary resources and fiscal oversight; and
5. Promote rapid dissemination of significant research finding
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
-
批准号:9153292
-
项目类别:
-
资助金额:$39.52万
-
财政年份:2016
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
-
批准号:9518657
-
项目类别:
-
资助金额:$39.52万
-
财政年份:2016
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Functional and biologic significance of deacetylase3 inhibition in myeloma
-
批准号:8757662
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2014
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Functional and biologic significance of deacetylase3 inhibition in myeloma
-
批准号:9320918
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2014
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Functional and biologic significance of deacetylase3 inhibition in myeloma
-
批准号:8916052
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2014
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Functional and biologic significance of deacetylase3 inhibition in myeloma
-
批准号:9127920
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2014
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Project 3. Oncogenomics to identify and validate novel targeted therapies in myeloma
-
批准号:10226194
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2011
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Project 3: Defining the biologic role and therapeutic implications of lncRNA in multiple myeloma
-
批准号:10555733
-
项目类别:
-
资助金额:$31.35万
-
财政年份:2011
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Administrative and Clinical Support
-
批准号:8249894
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2011
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Oncogenomics to Identify and Validate Novel Targeted Therapies in Multiple Myelom
-
批准号:8066221
-
项目类别:
-
资助金额:$26.31万
-
财政年份:2011
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Oncogenomics to Identify and Validate Novel Targeted Therapies in Multiple Myelom
-
批准号:8566798
-
项目类别:
-
资助金额:$21.48万
-
财政年份:2011
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Targeting Myeloma Cell-Host Bone Marrow Interactions
-
批准号:8249890
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2011
-
负责人:KENNETH C. ANDERSON
-
依托单位:
SPORE in Myeloma
-
批准号:7915014
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2009
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Administrative and Clinical Support
-
批准号:7782206
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2009
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Host-Tumor Cell Interactions in Myeloma: Therapeutic Applications
-
批准号:7908039
-
项目类别:
-
资助金额:$51.49万
-
财政年份:2009
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Targeting Myeloma Cell-Host Bone Marrow Interactions
-
批准号:7782200
-
项目类别:
-
资助金额:$102.55万
-
财政年份:2009
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Career Development Program
-
批准号:7507332
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2008
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Developmental Research Program
-
批准号:7507331
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2008
-
负责人:KENNETH C. ANDERSON
-
依托单位:
P-1: Proteosome-directed novel myeloma therapies
-
批准号:7507309
-
项目类别:
-
资助金额:$21.18万
-
财政年份:2008
-
负责人:KENNETH C. ANDERSON
-
依托单位:
Specialized Program of Research Excellence in Myeloma
-
批准号:6941666
-
项目类别:
-
资助金额:$225.29万
-
财政年份:2003
-
负责人:KENNETH C. ANDERSON
-
依托单位:
海外基金